HRP20020258B1 - Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive - Google Patents

Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Info

Publication number
HRP20020258B1
HRP20020258B1 HR20020258A HRP20020258A HRP20020258B1 HR P20020258 B1 HRP20020258 B1 HR P20020258B1 HR 20020258 A HR20020258 A HR 20020258A HR P20020258 A HRP20020258 A HR P20020258A HR P20020258 B1 HRP20020258 B1 HR P20020258B1
Authority
HR
Croatia
Prior art keywords
drospirenone
ethinylestradiol
contraceptive
pharmaceutical combination
active ingredient
Prior art date
Application number
HR20020258A
Other languages
English (en)
Croatian (hr)
Inventor
Heil Wolfgang
Hilman J�rgen
Lipp Ralph
Heithecker Renate
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020258(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of HRP20020258A2 publication Critical patent/HRP20020258A2/hr
Publication of HRP20020258B1 publication Critical patent/HRP20020258B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HR20020258A 1999-08-31 2002-03-27 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive HRP20020258B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (2)

Publication Number Publication Date
HRP20020258A2 HRP20020258A2 (en) 2005-02-28
HRP20020258B1 true HRP20020258B1 (en) 2007-05-31

Family

ID=26153358

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020258A HRP20020258B1 (en) 1999-08-31 2002-03-27 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Country Status (11)

Country Link
CN (1) CN1223350C (no)
BG (2) BG109749A (no)
CA (1) CA2382426C (no)
EE (1) EE05317B1 (no)
HR (1) HRP20020258B1 (no)
IL (2) IL197396A (no)
MX (1) MXPA02002043A (no)
NO (3) NO327588B3 (no)
RU (4) RU2449796C9 (no)
SK (1) SK287634B6 (no)
UA (1) UA81387C2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
KR100518102B1 (ko) * 1996-07-26 2005-10-04 와이어쓰 프로게스틴과 에스트로겐의 혼합물을 포함하는 단일상 피임약 키트

Also Published As

Publication number Publication date
IL200482A0 (en) 2011-07-31
BG106533A (bg) 2002-10-31
RU2269342C9 (ru) 2007-10-27
CN1223350C (zh) 2005-10-19
RU2482853C2 (ru) 2013-05-27
EE200900049A (et) 2009-10-15
NO327588B1 (no) 2009-08-31
RU2396082C2 (ru) 2010-08-10
BG65204B1 (bg) 2007-07-31
RU2269342C2 (ru) 2006-02-10
RU2449796C9 (ru) 2007-10-27
RU2005131868A (ru) 2007-04-20
NO20083854L (no) 2002-04-26
SK287634B6 (sk) 2011-04-05
UA81387C2 (en) 2008-01-10
IL197396A (en) 2010-04-29
EE05317B1 (et) 2010-08-16
RU2449796C2 (ru) 2006-02-10
NO20091809L (no) 2002-04-26
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
CA2382426A1 (en) 2001-03-08
MXPA02002043A (es) 2003-08-20
HRP20020258A2 (en) 2005-02-28
RU2010114825A (ru) 2011-10-20
CN1407895A (zh) 2003-04-02
NO2010004I1 (no) 2010-03-22
SK2572002A3 (en) 2002-11-06
NO327588B3 (no) 2011-05-16

Similar Documents

Publication Publication Date Title
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
HRP20090418T1 (en) Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate
TW355683B (en) Composition containing micronized nebivolol
WO2004066910A3 (en) Controlled release modifying complex and pharmaceutical compositions thereof
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
AP1954A (en) Controlled release compositions comprising nimesulide.
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
HRP20100513T1 (en) Multi-phase contraceptive preparation based on a natural estrogen
AP2003002763A0 (en) Controlled release formulations for oral administration
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
EA200701389A1 (ru) Твёрдая пероральная лекарственная форма для контрацепции
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
TW200640468A (en) Pharmaceutical product for oral contraception
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
AR043470A2 (es) Una composicion farmaceutica para ser usada como anticonceptivo
HRP20020666B1 (en) Drospirenone for hormone replacement therapy
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

PNAN Change of the applicant name, address/residence

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, PATENTS

PNAN Change of the applicant name, address/residence

Owner name: BAYER PHARMA AKTIENGESELLSCHAFT, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190725

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20200831